Mef2d: a novel transcription factor in type 2 allergic lung inflammation.
Signal transduction and targeted therapy
View this publicationInstitute of Clinical Chemistry and Clinical Pharmacology
BMZII, Venusberg-Campus 1, 53127 Bonn
Our research team works to understand the metabolic regulation and the role of tissue-resident lymphocytes in the maintenance of tissues homeostasis and during cancer development. Our aim is to uncover how dietary and host-derived metabolite availability influences immune cells in the tissues and the tumor microenvironment (TME). As the TME is metabolically challenging and immunosuppressive, our final goal is to support anti-tumorimmunity and improve treatment efficacy by targeting metabolic pathways.
Recent publications
-
-
Host-pathogen interactions from a metabolic perspective: methods of investigation.
Microbes and infection
View this publication